Aloysius Dzigbordi Loglo

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Richard Odame Phillips, J. Robert, Kabiru Mohamed Abass et al. · The Lancet · 2020 · 110 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load

Michael Frimpong, Bernadette Agbavor, Mabel Sarpong Duah et al. · PLoS neglected tropical diseases · 2019 · 65 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay

Mabel Sarpong-Duah, Michael Frimpong, Malkin Saar et al. · PLoS neglected tropical diseases · 2017 · 32 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions

Louise Tzung-Harn Hsieh, Scott J Dos Santos, Belinda S. Hall et al. · PLoS Pathogens · 2022 · 22 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +17

Plasma Glial Fibrillary Acidic Protein, Copeptin, and Matrix Metalloproteinase-9 Concentrations among West African Stroke Subjects Compared with Stroke-Free Controls

Fred Stephen Sarfo, Dorcas Owusu, Sheila Adamu et al. · Journal of Stroke and Cerebrovascular Diseases · 2017 · 15 citations

Life Sciences, Neurology, Neuroscience +16